Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.26M | -5.04M | -8.50M | -10.30M | -9.55M |
| Total Depreciation and Amortization | 8.90K | 11.40K | 12.60K | 14.20K | 12.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 3.06M | 6.23M | 7.91M | 7.22M |
| Change in Net Operating Assets | 1.01M | 1.09M | 859.10K | 463.60K | -324.00K |
| Cash from Operations | -918.10K | -886.70K | -1.39M | -1.91M | -2.64M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 869.20K | -- | -- | -- | -- |
| Cash from Investing | 869.20K | 500.00 | 500.00 | 500.00 | 500.00 |
| Total Debt Issued | 653.00K | 770.50K | 1.12M | 530.00K | 1.15M |
| Total Debt Repaid | -127.00K | -172.50K | -199.00K | -123.70K | -163.30K |
| Issuance of Common Stock | 30.00K | 255.00K | 255.00K | 1.43M | 1.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -13.30K | -13.30K | -13.30K |
| Cash from Financing | 556.00K | 853.00K | 1.17M | 1.82M | 2.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 507.20K | -33.30K | -225.30K | -95.20K | -270.50K |